Icagen, Inc.
company.status.inactiveCIK 1518520fmd_0CZ8A0D3PMD4KY031RWTACBN2XServices · Services-Commercial Physical & Biological ResearchTemplate: Standard
Coverage: Jan 01, 2011 to Sep 30, 2019, 34 periods
| Line item | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | – | – | 23 | 14 |
| Cost of revenue | 0 | 1 | 1 | 1 | 2 | 6 | 11 | – |
| Gross profit | 0 | 1 | 0 | (0) | (0) | 6 | 11 | 4 |
| Research and development | 0 | 0 | 0 | – | – | – | – | – |
| Selling, general and administrative | 2 | 2 | 4 | 5 | 5 | 8 | 14 | 10 |
| Total operating expenses | 2 | 2 | 5 | 5 | 6 | 9 | 16 | 12 |
| Operating income | (2) | (1) | (4) | (5) | (6) | (3) | (4) | (9) |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 3 |
| Interest and investment income | – | – | – | – | – | – | 1 | – |
| Other non-operating income (expense) | (0) | 0 | 1 | 5 | (3) | (2) | (2) | (5) |
| Income before taxes | – | – | – | 0 | (9) | (6) | (6) | (13) |
| Income tax expense | – | – | – | – | 0 | 0 | – | – |
| Net income from continuing operations | – | – | – | – | (9) | (6) | – | – |
| Net income | (2) | (1) | (4) | 0 | (9) | (6) | (6) | (13) |
| Net income to common shareholders | (2) | (1) | (6) | (1) | (9) | (6) | (6) | (13) |